Morgan Stanley’s Enveric Biosciences ENVB Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $15.8K | Buy |
+13,020
| New | +$15.8K | ﹤0.01% | 6720 |
|
|
2024
Q2 | – | Sell |
-1
| Closed | -$1 | – | 7876 |
|
|
2024
Q1 | $1 | Sell |
1
-1
| -50% | -$1 | ﹤0.01% | 7811 |
|
|
2023
Q4 | $2 | Buy |
2
+1
| +100% | +$1 | ﹤0.01% | 7805 |
|
|
2023
Q3 | $2 | Hold |
1
| – | – | ﹤0.01% | 7594 |
|
|
2023
Q2 | $3 | Hold |
1
| – | – | ﹤0.01% | 7630 |
|
|
2023
Q1 | $2 | Hold |
1
| – | – | ﹤0.01% | 7695 |
|
|
2022
Q4 | $2 | Sell |
1
-1
| -50% | -$2 | ﹤0.01% | 7855 |
|
|
2022
Q3 | $0 | Buy |
2
+1
| +100% | – | ﹤0.01% | 7742 |
|
|
2022
Q2 | $0 | Hold |
1
| – | – | ﹤0.01% | 7847 |
|
|
2022
Q1 | $0 | Sell |
1
-1
| -50% | – | ﹤0.01% | 7999 |
|
|
2021
Q4 | $0 | Buy |
2
+1
| +100% | – | ﹤0.01% | 8004 |
|
|
2021
Q3 | $0 | Hold |
1
| – | – | ﹤0.01% | 7953 |
|
|
2021
Q2 | $0 | Hold |
1
| – | – | ﹤0.01% | 7757 |
|
|
2021
Q1 | $0 | Hold |
1
| – | – | ﹤0.01% | 7501 |
|
|
2020
Q4 | $0 | Hold |
1
| – | – | ﹤0.01% | 7053 |
|
|
2020
Q3 | $0 | Hold |
1
| – | – | ﹤0.01% | 6756 |
|
|
2020
Q2 | $0 | Hold |
1
| – | – | ﹤0.01% | 6633 |
|
|
2020
Q1 | $0 | Hold |
1
| – | – | ﹤0.01% | 6602 |
|
|
2019
Q4 | $0 | Sell |
1
-17
| -94% | – | ﹤0.01% | 6678 |
|
|
2019
Q3 | $0 | Hold |
18
| – | – | ﹤0.01% | 6668 |
|
|
2019
Q2 | $0 | Hold |
18
| – | – | ﹤0.01% | 6672 |
|
|
2019
Q1 | $0 | Sell |
18
-161
| -90% | – | ﹤0.01% | 6617 |
|
|
2018
Q4 | $0 | Buy |
179
+161
| +894% | – | ﹤0.01% | 6625 |
|
|
2018
Q3 | $0 | Hold |
18
| – | – | ﹤0.01% | 6730 |
|
|
2018
Q2 | $0 | Sell |
18
-2,700
| -99% | – | ﹤0.01% | 6686 |
|
|
2018
Q1 | $4K | Buy |
2,718
+2,700
| +15,000% | +$3.97K | ﹤0.01% | 6421 |
|
|
2017
Q4 | $0 | Buy |
+18
| New | – | ﹤0.01% | 6587 |
|